644 related articles for article (PubMed ID: 16782925)
21. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
22. Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging.
Kimsey TF; Cohen T; Patel A; Busam KJ; Brady MS
Ann Surg Oncol; 2009 May; 16(5):1176-83. PubMed ID: 19224283
[TBL] [Abstract][Full Text] [Related]
23. Results of sentinel lymph node biopsy in patients with thin melanoma.
Wong SL; Brady MS; Busam KJ; Coit DG
Ann Surg Oncol; 2006 Mar; 13(3):302-9. PubMed ID: 16485151
[TBL] [Abstract][Full Text] [Related]
24. Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary?
Elias N; Tanabe KK; Sober AJ; Gadd MA; Mihm MC; Goodspeed B; Cosimi AB
Arch Surg; 2004 Apr; 139(4):400-4; discussion 404-5. PubMed ID: 15078708
[TBL] [Abstract][Full Text] [Related]
25. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
26. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
[TBL] [Abstract][Full Text] [Related]
27. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma.
Starz H; Balda BR; Krämer KU; Büchels H; Wang H
Cancer; 2001 Jun; 91(11):2110-21. PubMed ID: 11391592
[TBL] [Abstract][Full Text] [Related]
28. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
[TBL] [Abstract][Full Text] [Related]
29. [Feasibility and technical problems of sentinel node analysis in melanoma].
Mebazaa A; Kerob D; Toubert ME; Verola O; Servant JM; Baccard M; Billotey C; Bustamante K; Vandici FO; Basset-Seguin N; Ollivaud L; Morel P; Lebbé C
Ann Chir Plast Esthet; 2007 Feb; 52(1):14-23. PubMed ID: 17141391
[TBL] [Abstract][Full Text] [Related]
30. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node status in melanoma: a valuable prognostic factor?
Topar G; Eisendle K; Zelger B; Fritsch P
Br J Dermatol; 2006 Jun; 154(6):1080-7. PubMed ID: 16704637
[TBL] [Abstract][Full Text] [Related]
32. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.
Pearlman NW; McCarter MD; Frank M; Hurtubis C; Merkow RP; Franklin WA; Gonzalez R; Lewis K; Roaten JB; Robinson WA
Am J Surg; 2006 Dec; 192(6):878-81. PubMed ID: 17161112
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma.
Vuylsteke RJ; Borgstein PJ; van Leeuwen PA; Gietema HA; Molenkamp BG; Statius Muller MG; van Diest PJ; van der Sijp JR; Meijer S
Ann Surg Oncol; 2005 Jun; 12(6):440-8. PubMed ID: 15864481
[TBL] [Abstract][Full Text] [Related]
34. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
[TBL] [Abstract][Full Text] [Related]
35. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
36. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
[TBL] [Abstract][Full Text] [Related]
38. Influence of sentinel lymph node tumor burden on survival in melanoma.
Francischetto T; Spector N; Neto Rezende JF; de Azevedo Antunes M; de Oliveira Romano S; Small IA; Gil Ferreira C
Ann Surg Oncol; 2010 Apr; 17(4):1152-8. PubMed ID: 20087785
[TBL] [Abstract][Full Text] [Related]
39. [Anatomo-pathologic study of sentinel lymph nodes in melanoma. Analysis of 200 cases].
Riccioni L; Morigi F; Naldi S; Polverelli M; Morelli R; Fiscelli O; Landi G; Giangaspero F
Pathologica; 1999 Aug; 91(4):242-8. PubMed ID: 10630072
[TBL] [Abstract][Full Text] [Related]
40. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
Kruper LL; Spitz FR; Czerniecki BJ; Fraker DL; Blackwood-Chirchir A; Ming ME; Elder DE; Elenitsas R; Guerry D; Gimotty PA
Cancer; 2006 Nov; 107(10):2436-45. PubMed ID: 17058288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]